Akoya Biosciences Inc. announced that it received an unsolicited acquisition proposal from a third party, referred to as Party A, to acquire the company in an all-cash tender offer. The proposal offers Akoya shareholders $1.40 per share in cash. This development follows Akoya's earlier agreement to merge with Quanterix Corporation, under which Akoya would become a wholly owned subsidiary of Quanterix. Akoya's board, after consulting with financial and legal advisors, has determined that the unsolicited proposal could potentially lead to a superior offer and is therefore engaging in discussions with Party A to explore the proposal further.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akoya Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008337), on June 02, 2025, and is solely responsible for the information contained therein.